Dongyan Gao

921 total citations
21 papers, 771 citations indexed

About

Dongyan Gao is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Dongyan Gao has authored 21 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in Dongyan Gao's work include Liver Disease Diagnosis and Treatment (6 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Dongyan Gao is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Dongyan Gao collaborates with scholars based in China. Dongyan Gao's co-authors include Jihong Yao, Xiaofeng Tian, Yan Hu, Yan Zhao, Xiaohan Zhai, Li Lv, Xue Shi, Junjun Zhou, Jianxin Wang and Limei Han and has published in prestigious journals such as Scientific Reports, Life Sciences and Pharmaceutical Research.

In The Last Decade

Dongyan Gao

21 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongyan Gao China 15 368 212 125 115 83 21 771
Chengmu Hu China 18 387 1.1× 201 0.9× 75 0.6× 117 1.0× 72 0.9× 33 848
Ting Bai China 18 351 1.0× 199 0.9× 169 1.4× 181 1.6× 124 1.5× 26 826
Jinyong Peng China 17 381 1.0× 116 0.5× 60 0.5× 167 1.5× 73 0.9× 27 788
Xilan Tang China 13 260 0.7× 167 0.8× 108 0.9× 96 0.8× 67 0.8× 35 719
Mohamed A. Kandeil Egypt 16 304 0.8× 127 0.6× 60 0.5× 93 0.8× 88 1.1× 44 872
Xiaohan Zhai China 16 362 1.0× 142 0.7× 57 0.5× 101 0.9× 92 1.1× 31 745
Laila A. Eissa Egypt 22 399 1.1× 236 1.1× 89 0.7× 214 1.9× 100 1.2× 54 1.1k
Lei Dong China 16 424 1.2× 216 1.0× 55 0.4× 141 1.2× 122 1.5× 42 1.0k

Countries citing papers authored by Dongyan Gao

Since Specialization
Citations

This map shows the geographic impact of Dongyan Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyan Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyan Gao more than expected).

Fields of papers citing papers by Dongyan Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongyan Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyan Gao. The network helps show where Dongyan Gao may publish in the future.

Co-authorship network of co-authors of Dongyan Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Dongyan Gao. A scholar is included among the top collaborators of Dongyan Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongyan Gao. Dongyan Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sun, Ruimin, Xinyao Tian, Yang Li, et al.. (2022). The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. Redox Biology. 54. 102378–102378. 51 indexed citations
3.
4.
Wang, Ruiwen, Zhecheng Wang, Ruimin Sun, et al.. (2021). Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease. Frontiers in Pharmacology. 12. 775528–775528. 3 indexed citations
5.
Zhang, Shuai, Zhecheng Wang, Jie Zhu, et al.. (2018). Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats. Frontiers in Pharmacology. 8. 976–976. 33 indexed citations
6.
Zhu, Jie, Ruiwen Wang, Ting Xu, et al.. (2018). Salvianolic Acid A Attenuates Endoplasmic Reticulum Stress and Protects Against Cholestasis-Induced Liver Fibrosis via the SIRT1/HSF1 Pathway. Frontiers in Pharmacology. 9. 1277–1277. 29 indexed citations
7.
Shi, Xue, Yan Zhao, Zhecheng Wang, et al.. (2018). Salvianolic acid A alleviates chronic ethanol-induced liver injury via promotion of β-catenin nuclear accumulation by restoring SIRT1 in rats. Toxicology and Applied Pharmacology. 350. 21–31. 13 indexed citations
8.
Zhao, Yan, Xue Shi, Dongcheng Feng, et al.. (2017). Carnosic acid prevents COL1A2 transcription through the reduction of Smad3 acetylation via the AMPKα1/SIRT1 pathway. Toxicology and Applied Pharmacology. 339. 172–180. 8 indexed citations
9.
Gao, Meng, Hong Xu, Chenghong Zhang, et al.. (2016). Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer. Life Sciences. 165. 63–74. 16 indexed citations
10.
Liu, Hongyan, Hong Xu, Chenghong Zhang, et al.. (2016). Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer. Pharmaceutical Research. 33(11). 2828–2843. 15 indexed citations
11.
Guan, Xin, Meng Gao, Hong Xu, et al.. (2016). Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer. Drug Delivery. 23(9). 3307–3318. 46 indexed citations
12.
Zhang, Ning, Yan Hu, Wenjing Zeng, et al.. (2016). Salvianolic acid B protects against chronic alcoholic liver injury via SIRT1-mediated inhibition of CRP and ChREBP in rats. Toxicology Letters. 267. 1–10. 56 indexed citations
13.
Zhao, Yan, Xue Shi, Ning Zhang, et al.. (2016). New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats. Scientific Reports. 6(1). 28734–28734. 99 indexed citations
14.
Zeng, Wenjing, Wen Shan, Lili Gao, et al.. (2015). Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease. Scientific Reports. 5(1). 16013–16013. 99 indexed citations
15.
Chen, Zhao, Xiaohan Zhai, Yan Hu, et al.. (2014). Selective inhibition of protein kinase C β2 attenuates the adaptor P66Shc-mediated intestinal ischemia–reperfusion injury. Cell Death and Disease. 5(4). e1164–e1164. 27 indexed citations
16.
Li, Mingzhu, Yang Lü, Yan Hu, et al.. (2014). Salvianolic acid B protects against acute ethanol-induced liver injury through SIRT1-mediated deacetylation of p53 in rats. Toxicology Letters. 228(2). 67–74. 62 indexed citations
17.
Lin, Musen, Xiaohan Zhai, Guangzhi Wang, et al.. (2014). Salvianolic acid B protects against acetaminophen hepatotoxicity by inducing Nrf2 and phase II detoxification gene expression via activation of the PI3K and PKC signaling pathways. Journal of Pharmacological Sciences. 127(2). 203–210. 75 indexed citations
18.
Hu, Yan, Xiaohan Zhai, Musen Lin, et al.. (2013). Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice. Toxicology and Applied Pharmacology. 273(1). 68–76. 49 indexed citations
19.
Ding, Pingtian, Lin Mei, Dongyan Gao, et al.. (2011). Effect of pH, vehicles and chemical enhancers on the skin permeation of loratadine. Latin American Journal of Pharmacy. 2 indexed citations
20.
Gao, Dongyan, Limei Han, Lihong Zhang, Xiaoling Fang, & Jianxin Wang. (2009). Bioavailability of salvianolic acid B and effect on blood viscosities after oral administration of salvianolic acids in beagle dogs. Archives of Pharmacal Research. 32(5). 773–779. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengmu Hu Breakdown of academic impact, for papers by Ting Bai Breakdown of academic impact, for papers by Jinyong Peng Breakdown of academic impact, for papers by Xilan Tang Breakdown of academic impact, for papers by Mohamed A. Kandeil Breakdown of academic impact, for papers by Xiaohan Zhai Breakdown of academic impact, for papers by Laila A. Eissa Breakdown of academic impact, for papers by Lei Dong
Rankless by CCL
2026